Hypertension Clinical Trials

Showing 1541-1560 of 1,710 trials

Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome

NCT00666848

This study will measure the effect of the anti-diabetic agent sitagliptin on blood pressure in individuals with the metabolic syndrome. We will also measure the effect of sitagliptin on blood pressure in people already taking a blood pressure medication called an ACE inhibitor.

Metabolic SyndromeHypertension

Vanderbilt University24 participantsStarted Mar 2008

Nashville, Tennessee, United States

COMPLETEDNA

The Effect of Green Tea or Cocoa Extracts in Endothelial Dysfunction in Patients With Diabetes Mellitus

NCT01130727

The purpose of this study is to determine whether green tea or cocoa extracts are effective in improve endothelial dysfunction in patients with diabetes mellitus and nephropathy and arterial hypertension.

Diabetes MellitusDiabetic NephropathyArterial Hypertension

University of Campinas, Brazil51 participantsStarted May 2010

Campinas, São Paulo, Brazil

COMPLETEDPhase 4

Intensive Vasodilator Therapy in Patients With Essential Hypertension

NCT01180413

The purpose of this study is to determine whether add-on of intensive vasodilator therapy can improve the coronary perfusion and reduce the total peripheral resistance in patients with ongoing treatment for essential hypertension.

Essential HypertensionHigh Blood Pressure

Aarhus University Hospital48 participantsStarted Dec 2010

Aarhus, Denmark

Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome

The Effect of Green Tea or Cocoa Extracts in Endothelial Dysfunction in Patients With Diabetes Mellitus

Intensive Vasodilator Therapy in Patients With Essential Hypertension

Related Searches

A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension

Efficacy Study of Travoprost APS Versus TRAVATAN

Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation

Efficiency of XAL-EASE Device in Glaucoma and/or Ocular Hypertension (OHT) Patients, Treated With Xalatan or Xalacom

Treatment of Adiposity Related hypErTension (TARGET)

Atorvastatin in Pulmonary Hypertension

Internet-Based Strategic Transdisciplinary Approach To Risk Reduction And Treatment

A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho

A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin

Study of Association Between Maternal Uric Acid , Maternal and Fetal Outcome in Pregnant Women With Hypertension

Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

Effect of Ginseol Kg1 on Blood Pressure Lowering

A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine

Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome